Cook R C, Fradet G, English J C, Soos J, Müller N L, Connolly T P, Levy R D
University of British Columbia Lung Transplant Program, Vancouver, Canada.
Can Respir J. 1998 Nov-Dec;5(6):511-4. doi: 10.1155/1998/959750.
Advanced pulmonary disease is an unusual consequence of the intravenous injection of oral medications, usually developing over a period of several years. A number of patients with this condition have undergone lung transplantation for respiratory failure. However, a history of drug abuse is often considered to be a contraindication to transplantation in the context of limited donor resources. A patient with pulmonary talc granulomatosis secondary to intravenous methylphenidate injection who underwent successful lung transplantation and subsequently presented with recurrence of the underlying disease in the transplanted lung 18 months after transplantation is reported.
晚期肺部疾病是口服药物静脉注射的一种罕见后果,通常在数年时间内逐渐发展。许多患有这种疾病的患者因呼吸衰竭接受了肺移植。然而,在供体资源有限的情况下,药物滥用史通常被视为移植的禁忌症。本文报告了一名因静脉注射哌醋甲酯继发肺滑石肉芽肿的患者,该患者成功接受了肺移植,移植后18个月移植肺出现了基础疾病复发。